5032 results for "*oma"

in 30.64 milliseconds.

• Comprehensive gene expression analysis in renal cell carcinoma

  The goal is to elucidate the mechanisms of tumor initiation and progression, identify gene signatures associated with drug efficacy and adverse effects, and develop more accurate and reliable diagnostic methods and therapeutic targets.

  Study JGAS000913

• Multi-omic signatures in multiple myeloma

  Multiple myeloma (MM) is a genetically and clinically heterogeneous plasma-cell malignancy. Quadruplet therapy, combining anti-CD38 antibodies, immunomodulatory drugs, proteasome inhibitors, and dexamethasone, is now the standard induction treatment for newly diagnosed multiple myeloma (NDMM). To gain a comprehensive view of molecular changes in MM and their association with treatment response in this new standard care, we performed a multi-omic study of 423 NDMM from the MIDAS trial.

  Study EGAS50000001573